Recent updates of precision therapy for gastric cancer: Towards optimal tailored management

doi:10.3748/wjg.v22.i19.4638

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 19

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11056)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

868

WORD

339

HTML

5815

Figures (1-3)

279

Tables (1-2)

279

Sum=7580

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

427

Download

726

Sum=1153

Publishing Process of This Article

Item

Count

Browse

978

Download

1345

Sum=2323

May 21, 2016 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. May 21, 2016; 22(19): 4638-4650
Published online May 21, 2016. doi: 10.3748/wjg.v22.i19.4638

Full Size Figure Download Figure

Figure 1 Hepatocyte growth factor/mesenchymal epithelial transition factor and phosphoinositide 3-kinase/Akt/mammalian target of rapamycin pathway, and their inhibitors evaluated in gastric cancer patients. HGF: Hepatocyte growth factor; cMET: Mesenchymal epithelial transition factor; GAB1: Grb2-associated binder 1; GRB2: Growth factor-bound protein 2; PI3K: Phosphoinositide 3-kinase; PTEN: Phosphatase and tensin homolog; mTOR: Mammalian target of rapamycin.

Citation: Joo MK, Park JJ, Chun HJ. Recent updates of precision therapy for gastric cancer: Towards optimal tailored management. World J Gastroenterol 2016; 22(19): 4638-4650
URL: https://www.wjgnet.com/1007-9327/full/v22/i19/4638.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i19.4638